Synovial chondromatosis: the possible role of FGF 9 and FGF receptor 3 in its pathology

Primary synovial chondromatosis (PSC) is a rare disorder of the synovium typified by cartilaginous nodule formation within the synovial membrane. Fibroblast growth factor receptor 3 (FGFR3) is a recently described specific marker of mesenchymal precartilaginous stem cells. Expression patterns of FGFR3 and its specific ligand, fibroblast growth factor 9 (FGF 9), were evaluated both in situ and in cell cultures. Histologically, cells at the periphery of the cartilage nodules express FGFR3 and PCNA ( proliferating cell nuclear antigen). Elevated levels of FGF 9, its specific ligand, have been found in synovial fluids of patients with synovial chondromatosis. Synoviocytes but not chondrocytes from affected patients express FGF9 in culture. This pattern is absent in normal synovium and cartilage. Downregulation of FGF9 may provide a possible nonoperative therapy for PSC.

[1]  A. Hasharoni,et al.  Mesenchymal Cells and Growth Factors in Bunions , 1999, Foot & ankle international.

[2]  A. Hasharoni,et al.  Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cells. , 1999, Clinical orthopaedics and related research.

[3]  J. Biggart,et al.  Primary synovial chondromatosis: a clinicopathologic review and assessment of malignant potential. , 1998, Human pathology.

[4]  P. Hamilton,et al.  Cell proliferation studies in primary synovial chondromatosis , 1998, The Journal of pathology.

[5]  A. Hasharoni,et al.  The manipulated mesenchymal stem cells in regenerated skeletal tissues. , 1998, Cell transplantation.

[6]  S. Kadiyala,et al.  Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. , 1997, Cell transplantation.

[7]  N. Halperin,et al.  Resurfacing of Goat Articular Cartilage by Chondrocytes Derived From Bone Marrow , 1996, Clinical orthopaedics and related research.

[8]  R. I. Davis,et al.  C‐erb B‐2 STAINING IN PRIMARY SYNOVIAL CHONDROMATOSIS: A COMPARISON WITH OTHER CARTILAGINOUS TUMOURS , 1996, The Journal of pathology.

[9]  F. Mitelman,et al.  Chromosome rearrangements in synovial chondromatous lesions. , 1996, British Journal of Cancer.

[10]  B. Coughlan,et al.  p53 expression and DNA ploidy of cartilage lesions. , 1995, Human pathology.

[11]  A. Avivi,et al.  Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4. , 1995, Growth factors.

[12]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[13]  D. Burshtein,et al.  Maffucci's syndrome—The result of neural abnormalities? Evidence of mitogenic neurotransmitters present in enchondromas and soft tissue hemangiomas , 1994, Cancer.

[14]  D. Ogilvie-Harris,et al.  Generalized synovial chondromatosis of the knee: a comparison of removal of the loose bodies alone with arthroscopic synovectomy. , 1994, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[15]  J. Canoso,et al.  Tumors of soft tissues and bone. , 1993, Current opinion in rheumatology.

[16]  D. Robinson,et al.  Adhesion characteristics of chondrocytes cultured separately and in co‐cultures with synovial fibroblasts. , 1993, Cell biology international.

[17]  N. Halperin,et al.  Bone density in old chickens' metaphyses, as affected by local trauma and chondrocyte implantation. , 1993, Bulletin (Hospital for Joint Diseases (New York, N.Y.)).

[18]  N. Athanasou,et al.  An immunohistological study of cartilage and synovium in primary synovial chondromatosis , 1992, The Journal of pathology.

[19]  J. Aubin,et al.  Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone , 1988, The Journal of cell biology.

[20]  T. Sawai,et al.  A new decalcifying technique for immunohistochemical studies of calcified tissue, especially applicable to cell surface marker demonstration. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  E. BALEN BEJARANO,et al.  [Synovial osteochondromatosis]. , 1957, Revista clinica espanola.